Recognized globally for over two decades of innovation, leadership, and contributions to software engineering, Rupenkumar ...

As the president and CEO of COTA Healthcare, Sasu is working to solve a core problem in the industry: "how to use data to ...

The age of artificial intelligence (AI) has transformed our interactions, but threatens human dignity on a worldwide scale, ...

AI-generated papers are on the rise, and concerns grow around authorship, AI plagiarism, and maintaining trust in ...

In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

These capabilities illustrate the multifaceted promise of AI: speeding up scientific discovery, improving patient outcomes, ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...

Tents, trash and personal belongings have taken over a bench and sidewalk in the Broadway-Fillmore neighborhood — a sign of ...

Furthermore, the pharmaceutical industry can benefit significantly from quantum computing. Drug discovery involves simulating complex molecular interactions, which is a computationally intensive ...